ライフサイエンスコーパス: Salmonella typhi

1 a typhimurium and between S. typhimurium and Salmonella typhi.

2 reliably detect 1 colony-forming unit/mL of Salmonella Typhi.

3 otection against the intracellular bacterium Salmonella Typhi.

4 ciency virus type 1, Epstein Barr virus, and Salmonella typhi.

5 ococcus and the other by the PocR protein of Salmonella typhi.

6 murium and closely related organisms such as Salmonella typhi.

7 tal absence of bactericidal activity against Salmonella typhi 0 901 and Hemophilus influenzae, type b

8 ctor of the human-adapted bacterial pathogen Salmonella Typhi (6,7) , the cause of typhoid fever in h

9 The Vi capsular polysaccharide of Salmonella typhi, a licensed vaccine for typhoid fever i

10 in children and adults, respectively, while Salmonella Typhi accounted for 0.5% and 2.1%, respective

11 single dose of Vi polysaccharide vaccine for Salmonella typhi and 2 doses of rabies vaccine were give

12 %) isolates were available for analysis (164 Salmonella Typhi and 784 iNTS).

13 are a significant transmission mechanism for Salmonella typhi and dysentery-causing pathogens in this

14 Salmonella Typhi and iNTS were cultured from 194 (1.4%)

15 udy reports the microbiological landscape of Salmonella Typhi and invasive nontyphoidal Salmonella (i

16 The epidemiology of Salmonella Typhi and invasive nontyphoidal Salmonella (N

17 Salmonella Typhi and NTS are major causes of BSI in DRC;

18 ated antimicrobial susceptibility results of Salmonella Typhi and Paratyphi A isolates sent for testi

19 4 and 57 centisomes on the physical maps of Salmonella typhi and S. typhimurium, respectively.

20 ound to be effective for multidrug-resistant Salmonella typhi and safe in the pediatric population.

21 The host-pathogen interactions induced by Salmonella Typhi and Salmonella Paratyphi A during enter

22 erase chain reaction (qPCR) method to detect Salmonella Typhi and Salmonella Paratyphi A simultaneous

23 The probe set was able to detect clinical Salmonella Typhi and Salmonella Paratyphi A strains and

24 Enteric fever, caused by Salmonella Typhi and Salmonella Paratyphi A, is the lead

25 Salmonella Typhi and Typhimurium diverged only approxima

26 acute phase of human typhoid fever caused by Salmonella typhi, and experimental murine salmonellosis

27 various pathogens (Streptococcus pneumoniae, Salmonella typhi, and Mycobacterium tuberculosis), we de

28 Children <5 years accounted for 20.3% of Salmonella Typhi BSI episodes.

29 to restrict the intracellular human pathogen Salmonella Typhi, but its potential broader role in anti

30 purified capsular polysaccharide Vi Ag from Salmonella typhi can protect against typhoid fever, alth

31 ronic infection with other bacteria, notably Salmonella typhi, can also facilitate tumour development

32 the relative virulence of newly constructed Salmonella typhi carrier strains.

33 Shigella sonnei and Salmonella Typhi cause significant morbidity and mortali

34 Salmonella enterica serovar Typhi (Salmonella Typhi) causes an estimated 22 million typhoid

35 as Pseudomonas aeruginosa dTDP-Glc PPase and Salmonella typhi CDP-Glc PPase.

36 1.35 A of the crystal structure of DHQ1 from Salmonella typhi chemically modified by this ammonium de

37 gene and did not belong to the dominant H58 Salmonella Typhi clade.

38 es, in this work we evolved Cytolysin A from Salmonella typhi (ClyA) to a high level of soluble expre

39 ographic analysis of tyvelose epimerase from Salmonella typhi complexed with CDP.

40 Salmonella typhi continues to cause severe disease in ma

41 agments thereof were expressed in attenuated Salmonella typhi CVD 908-htrA, and the constructs were t

42 The disease is initiated when Salmonella typhi enters gastrointestinal epithelial cell

43 ic investigations have demonstrated that the Salmonella typhi enzyme complexed with the product CDP-g

44 , the intracellular bacterial human pathogen Salmonella Typhi exhibits strict host specificity.

45 Recently, we have demonstrated that Salmonella typhi flagella (STF) markedly decrease CD14 e

46 lood mononuclear cells (PBMC) in response to Salmonella typhi flagella (STF) were examined in culture

47 presentation 2; lymphocyte proliferation to Salmonella Typhi flagellin occurred in 63% and 67% of su

48 TF); a confirmed case required isolation of Salmonella Typhi from blood or stool.

49 mviA+ with that of the Escherichia coli and Salmonella typhi genes revealed a high degree of conserv

50 ophage elements present in the two published Salmonella typhi genomes, and in the database sequences

51 idence of the transcontinental spread of the Salmonella Typhi H58 haplotype, improved estimates of th

52 a composite antibiotic resistance island in Salmonella Typhi Haplotype 58.

53 immunized by the i.p. route with attenuated Salmonella typhi harboring the same DNA vaccine plasmid,

54 Vi antigen, the virulence factor of Salmonella typhi, has been used clinically as a molecula

55 ctious bacteria Salmonella enterica serovar (Salmonella typhi) in 10 muL of sample volume.

56 Invasive S. typhimurium and Salmonella typhi, independent of their ability to replic

57 ct association and causal mechanisms between Salmonella Typhi infection and GBC have not been establi

58 ntrol study of 45 patients and 123 controls, Salmonella Typhi infection was associated with drinking

59 epidemiological association between GBC and Salmonella Typhi infection, we show that Salmonella ente

60 of a suitable animal model in which to study Salmonella Typhi infection.

61 a more host-restricted lifestyle typical of Salmonella Typhi infections.

62 Furthermore, whereas control Salmonella typhi invaded all monolayer cells within 1 h,

63 Kinetic studies of Salmonella typhi invasion of INT407 cells at different m

64 In addition to Salmonella Typhi, invasive nontyphoidal Salmonella are i

65 Salmonella Typhi is an exclusive human pathogen that cau

66 Salmonella Typhi is the cause of typhoid fever, a diseas

67 Salmonella typhi is the etiologic agent of human typhoid

68 Salmonella Typhi is the leading cause of childhood bacte

69 Seventy-four Salmonella Typhi isolates (25%) were resistant to 1 or m

70 84/351) of NTS isolates and 46.2% (12/26) of Salmonella Typhi isolates.

71 gel electrophoresis (PFGE) were performed on Salmonella Typhi isolates.

72 enomic profiles of Salmonella serovar Typhi (Salmonella Typhi) isolates from the 15 confirmed case su

73 Immunogenicity data included Salmonella Typhi lipopolysaccharide (LPS)-specific immun

74 sion plasmids encoding foreign antigens in a Salmonella typhi live-vector vaccine strain such as CVD

75 [ELISPOT] assay), IgG serologic responses to Salmonella Typhi LPS, lymphocyte proliferation, and inte

76 hoprim-sulfamethoxazole (multidrug-resistant Salmonella Typhi [MDRST]).

77 e 392 cases of NTS meningitis and 9 cases of Salmonella Typhi meningitis.

78 ucture potential was conserved in homologous Salmonella typhi operons.

79 ard for diagnosis of enteric fever caused by Salmonella Typhi or Salmonella Paratyphi A or B is bone

80 Attenuated Salmonella typhi organisms which express genes encoding

81 mants containing pACTIItraQ plasmids and the Salmonella typhi pED208 traA gene cloned in pAS1CYH2.

82 is, Pseudomonas aeruginosa, Vibrio cholerae, Salmonella typhi, Porphyromonas gingivalis, and the mala

83 Among Salmonella Typhi, rates of multidrug resistance and decr

84 Enteric fever caused by Salmonella Typhi remains a major public health problem i

85 Reports from Asia of decreased Salmonella typhi resistance to chloramphenicol, attribut

86 , the gene encoding CDP-paratose synthase in Salmonella typhi, rfbS, has been identified and sequence

87 les was developed for the rapid detection of Salmonella typhi (S. typhi) in human serum.

88 Salmonella Typhi (S. Typhi) is normally not capable of p

89 ausing extremely lethal water borne pathogen Salmonella typhi (S. typhi) on modified isopore polycarb

90 etection of flagellin specific antibodies of Salmonella typhi (S. typhi).

91 provide insight into the molecular bases for Salmonella Typhi's host specificity and may help the dev

92 inhibiting effect against Escherichia coli, Salmonella typhi, Shigella dysenteriae, Streptococcus pn

93 ntibodies, which may provide immunity toward Salmonella typhi, Shigella, and Escherichia coli.

94 We engineered an attenuated Salmonella Typhi strain to express and export the F1 Ag

95 Oral vaccination with live-attenuated Salmonella Typhi strain Ty21a is modestly efficacious, b

96 The lack of antibiotic resistance among the Salmonella typhi strains isolated during this period, th

97 Salmonella typhimurium and Salmonella typhi strains were examined to better define

98 monitoring of antimicrobial resistance among Salmonella Typhi strains will help determine vaccination

99 y have a fitness advantage relative to other Salmonella Typhi strains.

100 saccharide capsules (K1 in E. coli and Vi in Salmonella typhi) swam toward the anode.

101 Other major causes of FBD deaths were Salmonella Typhi, Taenia solium and hepatitis A virus.

102 Here, high-resolution crystal structures of Salmonella typhi TAG in the unliganded form and in a ter

103 Typhoid toxin, a unique virulence factor of Salmonella Typhi (the cause of typhoid fever), recapitul

104 disease-causing bacteria, but experiments on Salmonella Typhi, the bacteria that causes Typhoid fever

105 Salmonella Typhi, the causative agent of typhoid fever,

106 id toxin is an essential virulence factor of Salmonella Typhi, the cause of typhoid fever.

107 Salmonella typhi, the etiologic agent of typhoid fever,

108 We isolated 16 Salmonella typhi TnphoA mutants that were defective for

109 the capacity of the gram-negative bacterium Salmonella typhi to induce IL-6 in the small intestine e

110 om broad-host Salmonella Typhimurium allowed Salmonella Typhi to survive and replicate within macroph

111 B. subtilis, Enterococcus, P. aeruginosa and Salmonella typhi) to antibiotics such as ampicillin and

112 were sequenced from a shotgun library of the Salmonella typhi Ty2 genome.

113 The phoP/phoQ virulence regulatory genes of Salmonella typhi Ty2 were deleted, and the resultant str

114 iella pneumoniae were compared with those of Salmonella typhi Ty2.

115 11 volunteers after rectal immunization with Salmonella typhi Ty21a.

116 ponse was generated in healthy volunteers by Salmonella typhi vaccination.

117 althy individuals were randomized to receive Salmonella typhi vaccine (a model of acute inflammation)

118 al immunization of US adults with attenuated Salmonella Typhi vaccine CVD 908-htrA.

119 Salmonella typhi vaccine strain CVD 908 can deliver hete

120 A single-dose, oral Salmonella typhi vaccine strain has been sought as a car

121 Salmonella typhi vaccine was used to generate a systemic

122 e administered a mild inflammatory stimulus, Salmonella typhi vaccine, or saline placebo to eight hea

123 conjugate of the capsular polysaccharide of Salmonella typhi, Vi, bound to nontoxic recombinant Pseu

124 Salmonella Typhi was isolated from 11 (0.3%) children at

125 , and 47 deaths from typhoid fever occurred; Salmonella Typhi was isolated from 27 (33%) of 81 patien

126 diatric medical patients presenting to QECH; Salmonella Typhi was isolated on 2054 occasions (1.2%) a

127 eavily contaminated with fecal coliforms; no Salmonella Typhi was isolated.

128 ion was intense, invasive NTS was common and Salmonella Typhi was uncommon, whereas the inverse was o

129 ampylobacter spp, Neisseria gonorrhoeae, and Salmonella typhi were included in the high-priority tier

130 entify genes belonging to the Fur regulon of Salmonella typhi which are absent from Escherichia coli

131 nity against pathogenic Salmonella including Salmonella Typhi which causes systemic infection, typhoi

132 almonella Typhimurium from 2002 to 2008, and Salmonella Typhi, which began in 2011 and was ongoing in

133 lucose-1-phosphate cytidylyltransferase from Salmonella typhi, which catalyzes the first step in the